Rx To Otc Switches 2009 --- Aarkstore Enterprise

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that

have been determined safe and effective as over-the-counter products. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.

As part of its coverage, this report includes

* Current Market for Rx to OTC across major categories

* Past Results of OTC Switches

* Products Most Likely to Switch to OTC

* Assessment of the Economic Downturn's Impact

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:

* Allergy, Cough, Cold, and Sinus Products

* Analgesics, NSAIDs, and Pain Treatments

* Anti-Infectives

* Gastrointestinal Drugs

* Hair Loss Products

* Hormones

* Oral Care

* Rectal Ointments

* Sleep-aids

* Smoking Cessation

* Weight Loss

In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include:

* Cholesterol-reducing Drugs

* Osteoporosis Treatments

* Overactive Bladder

* Sexual Dysfunction

The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug. Current and historical revenues for product segments include both the switched brands and OTC drugs containing switched ingredients. Forecasted data includes current products and forecasted switches which are outlined in the report.

The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

For more information, please visit :

http://www.aarkstore.com/reports/Rx-to-OTC-Switches-2009-13474.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore

POST COMMENT

Rfid: Scope, Viability And Company Analysis- Aarkstore Enterprise Hybrid Tv And Over The Top Tv Status Report- Aarkstore Enterprise Machine-to-machine (m2m) And Rfid- Aarkstore Enterprise End-to-end M2m, Third Edition- Aarkstore Enterprise Perdue Incorporated ---- Aarkstore Enterprise Montana Upstream Oil & Gas Fiscal Regime: 2010-aarkstore Enterprise Rfid: Scope, Viability And Company Analysis - Aarkstore Enterprise. Machine-to-machine (m2m) And Rfid - Aarkstore Enterprise. The Greenbrier Companies, Inc. - Swot Analysis - Aarkstore Enterprise. Ralcorp Holdings, Inc. - Swot Analysis - Aarkstore Enterprise. Hospira Inc - Swot Analysis - Aarkstore Enterprise. Barilla Holding - Swot Analysis - Aarkstore Enterprise. Bristol-myers Squibb Company - Swot Analysis - Aarkstore Enterprise.